• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Medifast Inc (NY: MED )

    18.82 -0.36 (-1.88%)
    Official Closing Price Updated: 7:00 PM EDT, Sep 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 149,122
    Open 19.20
    Bid (Size) 18.82 (1)
    Ask (Size) 19.83 (1)
    Prev. Close 19.18
    Today's Range 18.80 - 19.73
    52wk Range 17.73 - 83.60
    Shares Outstanding 11,616,233
    Dividend Yield 35.07%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MED Stock Earnings: Medifast Beats EPS, Beats Revenue for Q2 2024
    MED stock results show that Medifast beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Medifast Announces Second Quarter 2024 Financial Results
    From Medifast
    Via Business Wire

    Performance

    YTD
    -73.20%
    -73.20%
    1 Month
    -3.04%
    -3.04%
    3 Month
    -8.46%
    -8.46%
    6 Month
    -47.34%
    -47.34%
    1 Year
    -76.74%
    -76.74%

    More News

    Read More
    Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
    From Medifast, Inc.
    Via Business Wire
    Looking Into Medifast's Recent Short Interest
    Via Benzinga
    (MED) - Analyzing Medifast's Short Interest
    Via Benzinga
    Time to Unload: 3 Stocks in Deep Trouble to Sell Now
    Via InvestorPlace
    7 Consumer Staples Stocks to Buy at a 52-Week Low in July
    Via InvestorPlace
    3 Overlooked Telehealth Stocks Poised for a Comeback
    Via InvestorPlace
    Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
    Via InvestorPlace
    Medifast Named as One of The “Best Companies To Work For” by U.S. News & World Report
    From Medifast
    Via Business Wire
    3 Stocks to Sell as Ozempic Surges in Popularity
    Via InvestorPlace
    7 Small-Cap Value Stocks Leaving the S&P 500 in the Dust
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    7 Underappreciated Stocks With 25% Return Potential in 2024
    Via InvestorPlace
    LifeMD Can Surge on Its GLP-1 Offerings
    Via MarketBeat
    Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong
    Via InvestorPlace
    Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
    From Medifast
    Via Business Wire
    Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar
    Via InvestorPlace
    Top 4 Defensive Stocks You'll Regret Missing This Quarter
    Via Benzinga
    Gold Down Over 2%; 3M Profit Beats Expectations
    Via Benzinga
    Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views
    Via Benzinga
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Coursera (COUR) Stock Down 16% Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.